Skip to content

DRI-LYTE

by Mallinckrodt Critical Care

510(k) K780353

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK780353 Date5 Apr 1978ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KPO
Device Class
Class II
Regulation
21 CFR Part 876.5820
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

DRI-LYTE is a dialysate concentrate for hemodialysis, available in liquid or powder form. It is used in the preparation of dialysate solution for hemodialysis treatment.

The device is supplied as a concentrate for reconstitution and use in hemodialysis settings. It is classified as a Class II medical device under FDA regulation 876.5820, with product code KPO, and received traditional 510(k) clearance (K780353) on April 5, 1978, based on substantial equivalence.

Other devices from Mallinckrodt Critical Care

See all devices from Mallinckrodt Critical Care →

Questions

AI-generated answers, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is DRI-LYTE used for?

    DRI-LYTE is a dialysate concentrate used in the preparation of dialysate solution for hemodialysis treatment. It is reconstituted from liquid or powder form to create the solution that removes waste and excess fluid from blood during dialysis.

  • How is DRI-LYTE supplied and prepared for use?

    DRI-LYTE is supplied as a concentrate in either liquid or powder form, requiring reconstitution with water to prepare the final dialysate solution used in hemodialysis machines. This allows for flexible storage and on-site mixing based on clinical needs.

  • Is DRI-LYTE intended for single-use or multiple uses?

    DRI-LYTE is a concentrate intended for multiple uses after reconstitution; once mixed into dialysate solution, it is used in a single hemodialysis treatment session and then discarded, as the prepared dialysate is not reused.

  • What regulatory pathway was used for DRI-LYTE's market authorization?

    DRI-LYTE received traditional 510(k) clearance from the FDA on April 5, 1978 (K780353), based on demonstration of substantial equivalence to a legally marketed predicate device under regulation 876.5820.